Original Article
  

Analyzing the Role of CircSnx5 in an Animal Model of Multiple Sclerosis

Abstract

Circular RNAs (circRNAs) are endogenous non-coding RNA molecules that form covalently closed molecular loops. By regulating gene expression, circRNAs are known to play crucial roles in the development and progression of various diseases, including autoimmune, neoplastic, and neurological disorders.  
In this study, we examined the expression of circSnx5 in inflamed CNS tissue at different stages of experimental autoimmune encephalitis (EAE), an animal model for multiple sclerosis (MS), as well as in T cells that were activated and differentiated into different T helper phenotypes (Th1, Th17, Treg). EAE was induced and spinal cord tissues were isolated at different time points following disease induction. CD4+ T cells were isolated from mouse splenocytes and differentiated toward Th1, Th17, and Treg phenotypes, followed by the analysis of circSnx5 expression.
Compared with control mice, enhanced expression of both circular and linear forms of Snx5 was detected in EAE lumbar spinal cords at the peak and post-peak phases of the disease. However, the ratio of the circular to linear forms (CLR) was decreased in EAE mice compared with controls. Expression of circSnx5 was highly correlated with the levels of inflammatory cytokines in the spinal cord tissue. Significant decreases were observed in circSnx5 expression levels following polyclonal activation of splenocytes. The expression of circSnx5 was also downregulated in differentiated T cells directed toward Th1, Th17, and Treg.
Our findings suggest a potential role of circSnx5 in autoimmune neuroinflammation. The altered expression of circSnx5 during activation and differentiation may offer valuable insights into potential strategies for regulating inflammation in multiple sclerosis (MS).

1. Dolati S, Babaloo Z, Jadidi-Niaragh F, Ayromlou H, Sadreddini S, Yousefi M. Multiple sclerosis: Therapeutic applications of advancing drug delivery systems. Biomed Pharmacother. 2017;86:343-53.
2. Popescu BFG, Lucchinetti CF. Pathology of demyelinating diseases. Annu Rev Pathol. 2012;7:185-217.
3. Duffy SS, Lees JG, Moalem-Taylor G. The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis. Mult Scler Int. 2014;2014.
4. Ramaglia V, Rojas O, Naouar I, Gommerman JL. The ins and outs of central nervous system inflammation—lessons learned from multiple sclerosis. Annual Rev Immunol. 2021;39:199-226.
5. Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333-8.
6. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384-8.
7. Verduci L, Strano S, Yarden Y, Blandino G. The circ RNA–micro RNA code: emerging implications for cancer diagnosis and treatment. Mol oncol. 2019;13(4):669-80.
8. Wang R, Zhang S, Chen X, Li N, Li J, Jia R, et al. EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis. Mol cancer. 2018;17:1-12.
9. Bi J, Liu H, Dong W, Xie W, He Q, Cai Z, et al. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence. Mol Cancer. 2019;18:1-14.
10. Han J, Zhuang W, Feng W, Dong F, Hua F, Yao R, et al. The circular RNA circINPP4B acts as a sponge of miR-30a to regulate Th17 cell differentiation during progression of experimental autoimmune encephalomyelitis. Cell Mol Immunol. 2021;18(9):2177-87.
11. Mehta SL, Dempsey RJ, Vemuganti R. Role of circular RNAs in brain development and CNS diseases. Prog Neurobiol. 2020;186:101746.
12. Zhang H, Huang T, Hong Y, Yang W, Zhang X, Luo H, et al. The Retromer Complex and Sorting Nexins in Neurodegenerative Diseases. Front Aging Neurosci. 2018;10:79.
13. Hanley SE, Cooper KF. Sorting Nexins in Protein Homeostasis. Cells. 2020;10(1).
14. Tziouvara O, Petsana M, Kourounis D, Papadaki A, Basdra E, Braliou GG, et al. Characterization of the First Secreted Sorting Nexin Identified in the Leishmania Protists. Int J Mol Sci. 2024;25(7).
15. Itai N, Shimazu T, Kimura T, Ibe I, Yamashita R, Kaburagi Y, et al. The phosphorylation of sorting nexin 5 at serine 226 regulates retrograde transport and macropinocytosis. PLoS One. 2018;13(11):e0207205.
16. Li D-Y, Wen J-H, Liang S, Tang J-X. The Essential Role of Sorting Nexin 5 in Virus-Induced Autophagy. Front Immunol. ;13.
17. Sacharidou A, Chambliss K, Peng J, Barrera J, Tanigaki K, Luby-Phelps K, et al. Endothelial ERα promotes glucose tolerance by enhancing endothelial insulin transport to skeletal muscle. Nat Commun. 2023;14(1):4989.
18. Chen Q, Mang G, Wu J, Sun P, Li T, Zhang H, et al. Circular RNA circSnx5 Controls Immunogenicity of Dendritic Cells through the miR-544/SOCS1 Axis and PU.1 Activity Regulation. Mol Ther. 2020;28(11):2503-18.
19. Shahi SK, Freedman SN, Dahl RA, Karandikar NJ, Mangalam AK. Scoring disease in an animal model of multiple sclerosis using a novel infrared-based automated activity-monitoring system. Sci Rep. 2019;9(1):19194.
20. Jiao S, Wu S, Huang S, Liu M, Gao B. Advances in the identification of circular RNAs and research into circRNAs in human diseases. Front Genetics. 2021;12:665233.
21. Liu H, Zou Y, Chen C, Tang Y, Guo J. Current Understanding of Circular RNAs in Systemic Lupus Erythematosus. Front Immunol. 2021;12:628872.
22. Yin W, Zhang Z, Xiao Z, Li X, Luo S, Zhou Z. Circular RNAs in diabetes and its complications: Current knowledge and future prospects. Front Genet. 2022;13:1006307.
23. Li Z, Wang J, Lin Y, Fang J, Xie K, Guan Z, et al. Newly discovered circRNAs in rheumatoid arthritis, with special emphasis on functional roles in inflammatory immunity. Front Pharmacol. 2022;13:983744.
24. Cardamone G, Paraboschi EM, Rimoldi V, Duga S, Soldà G, Asselta R. The characterization of GSDMB splicing and backsplicing profiles identifies novel isoforms and a circular RNA that are dysregulated in multiple sclerosis. Int J Mol Sci. 2017;18(3):576.
25. Paraboschi EM, Cardamone G, Soldà G, Duga S, Asselta R. Interpreting non-coding genetic variation in multiple sclerosis genome-wide associated regions. Frontiers in Genetics. 2018;9:647.
26. Mohammed EM. Circular RNA in Multiple Sclerosis: Pathogenicity and Potential Biomarker Development: A Systematic Review. Epigenetics Insights. 2023;16:25168657231213195.
27. Huang Y, Bu T, Wu L, Sun H, Gao S, Huang D, et al. Identification of the circRNA/miRNA/mRNA network and hub mRNAs involved in multiple sclerosis through bioinformatics analysis. Epigenet Insights. 2023;16:251478.
28. Hewlett LJ, Prescott AR, Watts C. The coated pit and macropinocytic pathways serve distinct endosome populations. J Cell Biol. 1994;124(5):689-703.
29. Zhou Q, Li J, Ge C, Chen J, Tian W, Tian H. SNX5 suppresses clear cell renal cell carcinoma progression by inducing CD44 internalization and epithelial-to-mesenchymal transition. Molecular Therapy - Oncolytics. 2022;24:87-100.
Files
IssueArticles in Press QRcode
SectionOriginal Article(s)
Keywords
Circular RNAs Experimental autoimmune encephalomyelitis Multiple sclerosis Neuroinflammation SNX5
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Mohamed Khosroshahi L, Zabihi MR, Akbari B, Hadjati J, Noorbakhsh F. Analyzing the Role of CircSnx5 in an Animal Model of Multiple Sclerosis. Iran J Allergy Asthma Immunol. 2024;:1-10.